Premium-based site launches on October 18th during the BIO Investor Forum;
BIO is BioWeekSF’s inaugural “Welcome” Partner
SAN FRANCISCO, Sept. 28, 2017 -- Big3Bio, the leading aggregator service for the top three life sciences hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the upcoming launch of BioWeekSF (BioWeekSF.com), a premium website dedicated to optimizing the experience of attendees for the week of the J.P. Morgan Healthcare Conference in San Francisco, January 7-12, 2018 (“JPM Week”).
BioWeekSF is a valuable, must-have resource for JPM Week attendees, providing exclusive discounts, important news and updates, a portal to all events, customized consulting services, and more for this gathering of more than 40,000 investors, company executives, analysts, bankers, journalists, and other interested parties.
“Last year, our ‘On Your Mark: 2017’ guide for JPM Week was very well received, and our most downloaded publication,” says Tilton Little, publisher of Big3Bio. “This year we are building on that success with BioWeekSF, the ultimate resource for JPM Week participants.”
Big3Bio is also proud to announce that the Biotechnology Innovation Organization (BIO) has signed on as BioWeekSF’s inaugural “Welcome” Partner. To benefit the biotech community, BIO is offering complimentary access to the BIO One-on-One Partnering™ system during JPM Week to make it easier and more affordable to partner in downtown San Francisco.
“BIO One-on-One Partnering will allow you to request and schedule meetings with biotechs, investors, in-licensors, and others, saving you time and energy coordinating meetings during the jam-packed JPM Week,“ says Willie Reaves, director of Partnering Products & Services at BIO. “We look forward to working with Big3Bio to provide this free resource to BioWeekSF members.”
BioWeekSF will launch on October 18th during the BIO Investor Forum in San Francisco, along with an invite-only reception. The site will run from October 18 through JPM Week at a rate of $99 per individual membership. As a special part of its premium content, BioWeekSF will offer access to all types of experts who can answer specific questions and guide both sides of the partnering and fundraising table.
“Attending JPM Week is a must for almost everyone in the business of biopharma and healthcare,” says Little. “They go to sow the seeds of potential partnerships, seek investors, or just to create visibility in an increasingly crowded space. BioWeekSF will make sense out of this chaos and deliver a great overall value for attendees during this crucial week.”
BioWeekSF, BIO, and BIO’s provision of the BIO One-on-One Partnering™ system are not affiliated with J.P. Morgan or the J.P. Morgan Healthcare Conference.
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
About Big3Bio
Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives. More information is available at www.bigcom.bio. Subscribe to the Big3Bio newsletters at www.big3bio.com.
Contact: Robert Slocumb [email protected]


Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bill Ackman Eyes New Fund to Bet Against Market Complacency
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 



